Pediatrix Medical Group, Inc. MD
Set alert
At close · Oct 30
After hours · Oct 30, 5:05 PM ET
- YTD
- +39.41%
- 1 year
- +71.48%
- Open
- 29.48
- Prev close
- 29.18
- Mkt cap
- 2.33B
- Vol
- 1.11M
- Avg vol
- 753.01K
- EPS
- 2.09
- P/E
- 14.27
- Div yield
- 0.00%
More statistics
- Low
- 29.07
- High
- 29.97
- Forward P/E
- 12.20
- Beta
- 0.00
- Short ratio
- 5.77
- Inst. own
- 107.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 18, 2027
- 50-d avg
- 26.86
- 200-d avg
- 23.83
- 1y target
- 28.50
News
-
1 day ago benzinga.com
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.
1 day ago marketbeat.com
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
Pediatrix Medical Group NYSE: MD reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery.…
2 days ago seekingalpha.com
Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO &…
2 days ago benzinga.com
Pediatrix Medical Group Q3 2026 Earnings Call Transcript
Pediatrix Medical Group (NYSE:MD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
2 days ago zacks.com
Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.
-
2 days ago benzinga.com
Pediatrix Medical Group Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $501.374M Beat $498.144M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 7.46 percent increase over earnings of…
2 days ago businesswire.com
Pediatrix Medical Group Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
1 week ago businesswire.com
Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.
3 weeks ago zacks.com
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
1 month ago businesswire.com
HB Wealth Expands Into Texas With Experienced Three-Advisor Team
ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD,…
1 month ago zacks.com
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
1 month ago defenseworld.net
Engineers Gate Manager LP Lowers Stock Position in Pediatrix Medical Group, Inc. $MD
Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 60.9% during the second quarter, according to its most recent filing with the Securities and Exchange…
1 month ago zacks.com
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
1 month ago defenseworld.net
Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey
Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two…
1 month ago zacks.com
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
2 months ago zacks.com
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2 months ago gurufocus.com
TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's TEZSPIREÂ (te
2 months ago zacks.com
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 months ago benzinga.com
This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.
-
2 months ago benzinga.com
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
2 months ago zacks.com
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
2 months ago zacks.com
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
-
2 months ago benzinga.com
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
2 months ago zacks.com
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.
2 months ago marketbeat.com
Pediatrix Medical Group Q2 Earnings Call Highlights
Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger…
2 months ago seekingalpha.com
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
2 months ago benzinga.com
Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
-
2 months ago benzinga.com
Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 18.87 percent increase over earnings of…
-
3 months ago benzinga.com
Pediatrix Reports Q2 Payor Mix Remains Stable, No Material Changes In Net Revenue Trends; Reaffirms FY26 Adj EBITDA Outlook Of $280M-$300M
Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today provided an update on its second quarter 2026 business trends.In response to…
-
3 months ago benzinga.com
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.
4 months ago benzinga.com
Under the Radar: 5 Small-Cap Stocks Wall Street Is Missing
One of the biggest mistakes investors make is spending all their time looking for what is cheap and almost no time looking for what is working. Do not get me wrong. I love cheap stocks. Anyone who…
-
5 months ago benzinga.com
Pediatrix Medical Group Publishes New Research On Probiotic Use And Necrotizing Enterocolitis In Preterm Infants
Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm…
-
5 months ago benzinga.com
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.
5 months ago benzinga.com
Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call
Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call
-
6 months ago benzinga.com
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $23
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $21 to $23.
6 months ago benzinga.com
Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares dip 7.6% in pre-market trading.
-
7 months ago benzinga.com
Pediatrix Medical Group Expands Tennessee Footprint Through Collaboration With Tennessee Maternal-Fetal Medicine
Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine,…
-
8 months ago benzinga.com
UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $22
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.
-
8 months ago benzinga.com
Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $21
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $24 to $21.
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
8 months ago benzinga.com
Earnings Scheduled For February 19, 2026
Earnings Scheduled For February 19, 2026
-
8 months ago benzinga.com
Pediatrix Medical Group Q4 Adj. EPS $0.50 Misses $0.54 Estimate, Sales $493.771M Beat $486.228M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.54 by 7.24 percent. This is a 1.96 percent decrease over earnings of…
8 months ago benzinga.com
Earnings Outlook For Pediatrix Medical Group
Earnings Outlook For Pediatrix Medical Group
-
11 months ago benzinga.com
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $24
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $17 to $24.
-
12 months ago benzinga.com
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 months ago benzinga.com
Earnings Scheduled For November 3, 2025
Earnings Scheduled For November 3, 2025
-
12 months ago benzinga.com
Pediatrix Medical Group Q3 Adj. EPS $0.67 Beats $0.47 Estimate, Sales $492.875M Beat $476.493M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.47 by 43.78 percent. This is a 52.27 percent increase over earnings of…